TREA

Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain

Follow

Information

  • Research Project
  • 10450300
  • ApplicationId
    10450300
  • Core Project Number
    U44NS115692
  • Full Project Number
    4U44NS115692-02
  • Serial Number
    115692
  • FOA Number
    RFA-NS-19-020
  • Sub Project Id
  • Project Start Date
    9/1/2021 - 3 years ago
  • Project End Date
    8/31/2024 - 5 months ago
  • Program Officer Name
    CYWIN, CHARLES L
  • Budget Start Date
    9/1/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    8/13/2021 - 3 years ago
Organizations
Information

Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain

IC Name
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
  • Activity
    U44
  • Administering IC
    NS
  • Application Type
    4
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    1439283
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    853
  • Ed Inst. Type
  • Funding ICs
    NINDS:1439283\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZNS1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    4E THERAPEUTICS INC.
  • Organization Department
  • Organization DUNS
    038406094
  • Organization City
    AUSTIN
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    78756
  • Organization District
    UNITED STATES